Litcius/Paper detail

FDA approval of dapagliflozin for chronic kidney disease: a remarkable achievement?

Tazeen H. Jafar

2021The Lancet31 citationsDOI

Topics & Concepts

Kidney diseaseScopusMedicineDiseasePopulationDiabetes mellitusInternal medicineMEDLINEEndocrinologyEnvironmental healthPolitical scienceLawDiabetes Treatment and ManagementChronic Kidney Disease and DiabetesRenal Diseases and Glomerulopathies